Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials
Backgrounds. Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented. The aim of this study is to evaluate the safety and efficacy of the DCB-only strategy compared to other percutaneous cor...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2023/3121601 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546559636537344 |
|---|---|
| author | Wenyi Zhang Mingduo Zhang Jinfan Tian Min Zhang Yuan Zhou Xiantao Song |
| author_facet | Wenyi Zhang Mingduo Zhang Jinfan Tian Min Zhang Yuan Zhou Xiantao Song |
| author_sort | Wenyi Zhang |
| collection | DOAJ |
| description | Backgrounds. Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented. The aim of this study is to evaluate the safety and efficacy of the DCB-only strategy compared to other percutaneous coronary intervention strategies for de novo coronary lesions. Methods. The PubMed, Embase, Web of Science, and Cochrane Library Central Register of Controlled Trials (CENTRAL) electronic databases were searched for randomized controlled trials published up to May 6, 2023. The primary outcomes were major adverse cardiac events and late lumen loss. Results. A total of eighteen trials with 3336 participants were included. Compared with drug-eluting stents, the DCB-only strategy was associated with a similar risk of major adverse cardiac events (risk ratio RR=0.90; 95% confidence interval (CI): 0.59 to 1.37, P=0.631) and a significant decrease in late lumen loss (standardized mean difference SMD=−0.29, 95% CI: −0.53 to −0.04, P=0.021). This effect was consistent in subgroup analysis regardless of indication, follow-up time, drug-eluting stent type, and dual antiplatelet therapy duration. However, DCBs were inferior to DESs for minimum lumen diameter and percentage diameter stenosis. The DCB-only strategy showed significantly better outcomes for most endpoints compared to plain-old balloon angioplasty or bare metal stents. Conclusions. Interventions with a DCB-only strategy are comparable to those of drug-eluting stents and superior to plain-old balloon angioplasty or bare metal stents for the treatment of selected de novo coronary lesions. Additional evidence is still warranted to confirm the value of DCB before widespread clinical utilization can be recommended. |
| format | Article |
| id | doaj-art-d4e34dbdd3794e64b793005c8b2558a8 |
| institution | Kabale University |
| issn | 1755-5922 |
| language | English |
| publishDate | 2023-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiovascular Therapeutics |
| spelling | doaj-art-d4e34dbdd3794e64b793005c8b2558a82025-02-03T06:48:30ZengWileyCardiovascular Therapeutics1755-59222023-01-01202310.1155/2023/3121601Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical TrialsWenyi Zhang0Mingduo Zhang1Jinfan Tian2Min Zhang3Yuan Zhou4Xiantao Song5Department of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyBackgrounds. Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented. The aim of this study is to evaluate the safety and efficacy of the DCB-only strategy compared to other percutaneous coronary intervention strategies for de novo coronary lesions. Methods. The PubMed, Embase, Web of Science, and Cochrane Library Central Register of Controlled Trials (CENTRAL) electronic databases were searched for randomized controlled trials published up to May 6, 2023. The primary outcomes were major adverse cardiac events and late lumen loss. Results. A total of eighteen trials with 3336 participants were included. Compared with drug-eluting stents, the DCB-only strategy was associated with a similar risk of major adverse cardiac events (risk ratio RR=0.90; 95% confidence interval (CI): 0.59 to 1.37, P=0.631) and a significant decrease in late lumen loss (standardized mean difference SMD=−0.29, 95% CI: −0.53 to −0.04, P=0.021). This effect was consistent in subgroup analysis regardless of indication, follow-up time, drug-eluting stent type, and dual antiplatelet therapy duration. However, DCBs were inferior to DESs for minimum lumen diameter and percentage diameter stenosis. The DCB-only strategy showed significantly better outcomes for most endpoints compared to plain-old balloon angioplasty or bare metal stents. Conclusions. Interventions with a DCB-only strategy are comparable to those of drug-eluting stents and superior to plain-old balloon angioplasty or bare metal stents for the treatment of selected de novo coronary lesions. Additional evidence is still warranted to confirm the value of DCB before widespread clinical utilization can be recommended.http://dx.doi.org/10.1155/2023/3121601 |
| spellingShingle | Wenyi Zhang Mingduo Zhang Jinfan Tian Min Zhang Yuan Zhou Xiantao Song Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials Cardiovascular Therapeutics |
| title | Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials |
| title_full | Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials |
| title_fullStr | Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials |
| title_full_unstemmed | Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials |
| title_short | Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials |
| title_sort | drug coated balloon only strategy for de novo coronary artery disease a meta analysis of randomized clinical trials |
| url | http://dx.doi.org/10.1155/2023/3121601 |
| work_keys_str_mv | AT wenyizhang drugcoatedballoononlystrategyfordenovocoronaryarterydiseaseametaanalysisofrandomizedclinicaltrials AT mingduozhang drugcoatedballoononlystrategyfordenovocoronaryarterydiseaseametaanalysisofrandomizedclinicaltrials AT jinfantian drugcoatedballoononlystrategyfordenovocoronaryarterydiseaseametaanalysisofrandomizedclinicaltrials AT minzhang drugcoatedballoononlystrategyfordenovocoronaryarterydiseaseametaanalysisofrandomizedclinicaltrials AT yuanzhou drugcoatedballoononlystrategyfordenovocoronaryarterydiseaseametaanalysisofrandomizedclinicaltrials AT xiantaosong drugcoatedballoononlystrategyfordenovocoronaryarterydiseaseametaanalysisofrandomizedclinicaltrials |